Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novartis Ag ADR (NVS)

Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Health Canada approves Cosentyx®, a biologic therapy, for the treatment of adults with moderate to severe Hidradenitis Suppurativa (HS)

/CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that Health Canada has granted Cosentyx® (secukinumab) with a Notice of...

NVS : 101.80 (-1.01%)
3 Magnificent Stocks That Are Passive Income Machines

These three companies have track records that should please investors.

LLY : 800.17 (-0.37%)
ABBV : 160.80 (-1.31%)
NVS : 101.80 (-1.01%)
2 Magnificent Dividend Stocks to Hold for the Next Decade

The dividend is just one reason to buy these stocks.

NVS : 101.80 (-1.01%)
V : 275.79 (-0.06%)
Why Novartis Stock Topped the Market on Tuesday

A double beat on the latest quarterly results and raised guidance made investors happy.

NVS : 101.80 (-1.01%)
Novartis, Danaher rise; Nucor, Cadence Design Systems fall, Tuesday, 4/23/2024

Stocks that traded heavily or had substantial price changes on Tuesday: Novartis, Danaher rise; Nucor, Cadence Design Systems fall

NUE : 171.00 (-0.65%)
GM : 43.80 (-2.49%)
CDNS : 290.90 (+0.28%)
DHR : 267.41 (+0.32%)
NVS : 101.80 (-1.01%)
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript

NVS earnings call for the period ending March 31, 2024.

NVS : 101.80 (-1.01%)
Novartis: Q1 Earnings Snapshot

Novartis: Q1 Earnings Snapshot

NVS : 101.80 (-1.01%)
2 High-Yield Dividend Stocks to Buy and Hold for 10 Years

These income stocks look like good options at current levels.

BMY : 42.46 (+0.45%)
NVS : 101.80 (-1.01%)
Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly 4.9%.

Think globally with this high-yielding ETF.

TM : 216.46 (-1.32%)
NVS : 101.80 (-1.01%)
HSBC : 44.13 (-1.01%)
SHEL : 70.32 (-1.51%)
RHHBY : 31.7400 (-1.79%)
VYMI : 70.84 (-0.94%)
Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock

Next-generation cancer therapies are here. AstraZeneca - already an oncology leader - is going down the path of radiopharmaceuticals with its purchase of Fusion. Along with the other potential blockbuster...

AZN : 78.72 (-0.58%)
FUSN : 21.50 (+0.05%)
NVS : 101.80 (-1.01%)
LLY : 800.17 (-0.37%)
BMY : 42.46 (+0.45%)

Barchart Exclusives

Unusual Options Activity in Taiwan Semiconductor ADRs Today Highlight Its Value
Last week Taiwan Semiconductor, a large semiconductor fabrication company, said its April revenue spiked. Call options in TSM stock are having unusual activity today, underlining its underlying value. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar